Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Bristol Myers Squibb)"
Count: 2500
Selected: 0
| NCT ID | Title |
|---|
| NCT05638282 | A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants | ||
| NCT05633264 | A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan | ||
| NCT05625412 | A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors | ||
| NCT05625399 | A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma | ||
| NCT05620407 | A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus | ||
| NCT05617677 | A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) | ||
| NCT05615012 | A Study Investigating Interactions Between BMS-986322 and Rosuvastatin or Metformin in Healthy Participants | ||
| NCT05613088 | A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | ||
| NCT05605782 | A Post-Authorization, Long-term Study of Ozanimod Real-world Safety | ||
| NCT05599685 | A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer | ||
| NCT05582395 | A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy | ||
| NCT05579574 | A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants | ||
| NCT05577715 | A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC) | ||
| NCT05567510 | A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants | ||
| NCT05567458 | A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia. | ||
| NCT05556343 | A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy | ||
| NCT05556265 | A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata | ||
| NCT05552976 | A Study to Evaluate CC-92480 in Combination With Carfilzomib and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) | ||
| NCT05547490 | A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis | ||
| NCT05546151 | A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent | ||
| NCT05543629 | A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer | ||
| NCT05539976 | A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants | ||
| NCT05519085 | A Study to Evaluate CC-92480, Bortezomib and Dexamethasone (480Vd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) | ||
| NCT05517837 | A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants | ||
| NCT05498480 | Study of Relatlimab in Combination With Nivolumab in Chinese Participants | ||
| NCT05496192 | A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer | ||
| NCT05489705 | A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) | ||
| NCT05478499 | Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis | ||
| NCT05470985 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy | ||
| NCT05469737 | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) | ||
| NCT05445440 | A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine | ||
| NCT05432622 | A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy | ||
| NCT05426239 | Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database | ||
| NCT05421442 | A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database | ||
| NCT05421299 | A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate | ||
| NCT05420909 | A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC) | ||
| NCT05414175 | A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy | ||
| NCT05413044 | A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register | ||
| NCT05413018 | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission | ||
| NCT05409157 | A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants | ||
| NCT05407675 | A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors | ||
| NCT05405543 | A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese Participants | ||
| NCT05389722 | A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy Participants | ||
| NCT05382715 | A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis | ||
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05369832 | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice | ||
| NCT05362045 | A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants | ||
| NCT05350800 | A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants | ||
| NCT05337345 | A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants | ||
| NCT05337137 | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer |
